EMBC
Price
$14.48
Change
-$0.02 (-0.14%)
Updated
Aug 29 closing price
Capitalization
846.86M
114 days until earnings call
MTD
Price
$1301.04
Change
+$17.93 (+1.40%)
Updated
Aug 29 closing price
Capitalization
26.8B
67 days until earnings call
Interact to see
Advertisement

EMBC vs MTD

Header iconEMBC vs MTD Comparison
Open Charts EMBC vs MTDBanner chart's image
Embecta
Price$14.48
Change-$0.02 (-0.14%)
Volume$366.81K
Capitalization846.86M
Mettler-Toledo International
Price$1301.04
Change+$17.93 (+1.40%)
Volume$100.6K
Capitalization26.8B
EMBC vs MTD Comparison Chart in %
Loading...
EMBC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EMBC vs. MTD commentary
Aug 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMBC is a StrongBuy and MTD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 31, 2025
Stock price -- (EMBC: $14.48 vs. MTD: $1301.04)
Brand notoriety: EMBC and MTD are both not notable
EMBC represents the Pharmaceuticals: Other, while MTD is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: EMBC: 59% vs. MTD: 67%
Market capitalization -- EMBC: $846.86M vs. MTD: $26.8B
EMBC [@Pharmaceuticals: Other] is valued at $846.86M. MTD’s [@Medical Specialties] market capitalization is $26.8B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.67B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.98B. The average market capitalization across the [@Medical Specialties] industry is $10.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EMBC’s FA Score shows that 2 FA rating(s) are green whileMTD’s FA Score has 1 green FA rating(s).

  • EMBC’s FA Score: 2 green, 3 red.
  • MTD’s FA Score: 1 green, 4 red.
According to our system of comparison, EMBC is a better buy in the long-term than MTD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EMBC’s TA Score shows that 6 TA indicator(s) are bullish while MTD’s TA Score has 4 bullish TA indicator(s).

  • EMBC’s TA Score: 6 bullish, 4 bearish.
  • MTD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, EMBC is a better buy in the short-term than MTD.

Price Growth

EMBC (@Pharmaceuticals: Other) experienced а +1.75% price change this week, while MTD (@Medical Specialties) price change was -1.54% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.93%. For the same industry, the average monthly price growth was +6.00%, and the average quarterly price growth was +26.47%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.46%. For the same industry, the average monthly price growth was +7.37%, and the average quarterly price growth was +8.13%.

Reported Earning Dates

EMBC is expected to report earnings on Dec 23, 2025.

MTD is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.93% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (-0.46% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MTD($26.8B) has a higher market cap than EMBC($847M). MTD has higher P/E ratio than EMBC: MTD (32.99) vs EMBC (10.20). MTD YTD gains are higher at: 6.322 vs. EMBC (-27.377). MTD has higher annual earnings (EBITDA): 1.22B vs. EMBC (252M). EMBC has less debt than MTD: EMBC (1.55B) vs MTD (2.18B). MTD has higher revenues than EMBC: MTD (3.87B) vs EMBC (1.1B).
EMBCMTDEMBC / MTD
Capitalization847M26.8B3%
EBITDA252M1.22B21%
Gain YTD-27.3776.322-433%
P/E Ratio10.2032.9931%
Revenue1.1B3.87B28%
Total CashN/A61.8M-
Total Debt1.55B2.18B71%
FUNDAMENTALS RATINGS
MTD: Fundamental Ratings
MTD
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
3
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
72
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EMBCMTD
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
56%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 11 days ago
76%
Bullish Trend 18 days ago
61%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
EMBC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NMT11.330.14
+1.25%
Nuveen Massachusetts Quality Municipal Income Fund
MBNE28.690.05
+0.17%
SPDR® Nuveen Municipal Bond ESG ETF
LIAB154.30N/A
N/A
LifeX 2048 Infl-Prt Longevity Inc ETF
IDOG35.73-0.18
-0.49%
ALPS International Sector Div Dogs ETF
BITX50.96-3.81
-6.96%
2x Bitcoin Strategy ETF

EMBC and

Correlation & Price change

A.I.dvisor indicates that over the last year, EMBC has been loosely correlated with WAT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if EMBC jumps, then WAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMBC
1D Price
Change %
EMBC100%
+0.91%
WAT - EMBC
37%
Loosely correlated
+1.39%
MTD - EMBC
37%
Loosely correlated
+1.40%
RVTY - EMBC
36%
Loosely correlated
+0.99%
A - EMBC
35%
Loosely correlated
+0.56%
AZTA - EMBC
34%
Loosely correlated
+2.07%
More

MTD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTD
1D Price
Change %
MTD100%
+1.40%
A - MTD
82%
Closely correlated
+0.56%
RVTY - MTD
80%
Closely correlated
+0.99%
TMO - MTD
76%
Closely correlated
+0.61%
WAT - MTD
73%
Closely correlated
+1.39%
DHR - MTD
70%
Closely correlated
+0.26%
More